Cargando…
High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue
BACKGROUND: Squamous cell carcinoma of the tongue (tongue SCC) is a major subtype of head and neck squamous cell carcinoma (HNSCC), which is an intractable cancer under current therapeutics. ARF6 and its effector AMAP1 are often overexpressed in different types of cancers, such as breast cancer and...
Autores principales: | Otsuka, Yutaro, Sato, Hiroki, Oikawa, Tsukasa, Onodera, Yasuhito, Nam, Jin-Min, Hashimoto, Ari, Fukunaga, Kiyoshi, Hatanaka, Kanako C., Hatanaka, Yutaka, Matsuno, Yoshihiro, Fukuda, Satoshi, Sabe, Hisataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117685/ https://www.ncbi.nlm.nih.gov/pubmed/27871329 http://dx.doi.org/10.1186/s12964-016-0151-0 |
Ejemplares similares
-
Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells
por: Handa, Haruka, et al.
Publicado: (2017) -
ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance
por: Hashimoto, A, et al.
Publicado: (2016) -
P53- and mevalonate pathway–driven malignancies require Arf6 for metastasis and drug resistance
por: Hashimoto, Ari, et al.
Publicado: (2016) -
High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients
por: Sato, Hiroki, et al.
Publicado: (2014) -
ARF1 recruits RAC1 to leading edge in neutrophil chemotaxis
por: Mazaki, Yuichi, et al.
Publicado: (2017)